Literature DB >> 3196032

Biochemical analysis of a human epithelial surface antigen: differential cell expression and processing.

I J Thampoe1, J S Ng, K O Lloyd.   

Abstract

Epithelial surface antigen (ESA) is a glycoprotein with a distribution in vivo that is largely confined to human epithelial cells. Previous studies using a mouse monoclonal antibody (MH99) detecting ESA had shown that the antigen immunoprecipitated from most epithelial cancer cell lines has two chains (38,000 and 32,000 Da) when separated under reducing conditions and only one (38,000 Da) under nonreducing conditions. We now show that the 38-kDa band observed under nonreducing conditions consists of two species, one a 38-kDa single chain protein and the other a disulfide-linked dimer consisting of the 32-kDa chain bonded to a previously unrecognized 6-kDa chain. Pulse-chase studies have shown that ESA is synthesized as a 34-kDa protein which is glycosylated to a 38-kDa glycoprotein containing both high mannose and complex carbohydrate chains. With longer chase periods, a 32-kDa species also appears. Peptide mapping, together with the pulse-chase data, suggests that the 32- and 6-kDa species are formed from the 38-kDa protein, probably by limited proteolysis. Epithelial cell lines differ in their ratios of 38/32-kDa species, some cell lines having only the 38-kDa form. Incubation of radiolabeled extracts of cells having only the 38-kDa protein with unlabeled extracts of the other cell types resulted in progressive conversion of the 38-kDa species to the 32- and 6-kDa forms. Only cell lines expressing both forms of ESA are able to carry out this cleavage of the 38-kDa protein. This is a novel mechanism for generating cell-type related differences in cell surface glycoprotein expression. Finally, sequential immunoprecipitation experiments showed that the antigen detected by Ab MH99 is closely related or identical to that detected by Ab 17-1A, a previously described colon cancer antigen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3196032     DOI: 10.1016/0003-9861(88)90040-9

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

1.  Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions.

Authors:  M Balzar; I H Briaire-de Bruijn; H A Rees-Bakker; F A Prins; W Helfrich; L de Leij; G Riethmüller; S Alberti; S O Warnaar; G J Fleuren; S V Litvinov
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Matriptase-mediated cleavage of EpCAM destabilizes claudins and dysregulates intestinal epithelial homeostasis.

Authors:  Chuan-Jin Wu; Xu Feng; Michael Lu; Sohshi Morimura; Mark C Udey
Journal:  J Clin Invest       Date:  2017-01-17       Impact factor: 14.808

3.  Binding parameters of monoclonal antibodies reacting with ovarian carcinoma ascites cells.

Authors:  M J Mattes; K O Lloyd; J L Lewis
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.

Authors:  S V Litvinov; M P Velders; H A Bakker; G J Fleuren; S O Warnaar
Journal:  J Cell Biol       Date:  1994-04       Impact factor: 10.539

Review 5.  Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule.

Authors:  Monika Trzpis; Pamela M J McLaughlin; Lou M F H de Leij; Martin C Harmsen
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

6.  Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE.

Authors:  Tomaž Žagar; Miha Pavšič; Aljaž Gaber
Journal:  PeerJ       Date:  2021-05-21       Impact factor: 2.984

7.  KSA antigen Ep-CAM mediates cell-cell adhesion of pancreatic epithelial cells: morphoregulatory roles in pancreatic islet development.

Authors:  V Cirulli; L Crisa; G M Beattie; M I Mally; A D Lopez; A Fannon; A Ptasznik; L Inverardi; C Ricordi; T Deerinck; M Ellisman; R A Reisfeld; A Hayek
Journal:  J Cell Biol       Date:  1998-03-23       Impact factor: 10.539

8.  EpCAM proteolysis: new fragments with distinct functions?

Authors:  Ulrike Schnell; Jeroen Kuipers; Ben N G Giepmans
Journal:  Biosci Rep       Date:  2013-03-19       Impact factor: 3.840

9.  Comparison of monoclonal antibodies 17-1A and 323/A3: the influence of the affinity on tumour uptake and efficacy of radioimmunotherapy in human ovarian cancer xenografts.

Authors:  E Kievit; H M Pinedo; H M Schlüper; H J Haisma; E Boven
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Development and characterization of two human triple-negative breast cancer cell lines with highly tumorigenic and metastatic capabilities.

Authors:  Yanrong Su; Thomas J Pogash; Theresa D Nguyen; Jose Russo
Journal:  Cancer Med       Date:  2016-01-18       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.